Preclinical and clinical Drug development Plan up to PoC

As your partner in early clinical drug development, the Aepodia team will work in close collaboration with you to develop an optimal early-phase clinical research strategy and plan.

All relevant pharmaceutical, pharmacological, efficacy, toxicology, and metabolism information (preclinical and clinical) is evaluated to establish a clinical development plan to support a Go/No Go decision as quickly and as efficiently as possible.

Studies are designed to address primary key objectives and help the compound move forward to the next critical decision point.